These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2133112)

  • 1. Adenovirus E1A-dependent trans-activation of transcription.
    Nevins JR
    Semin Cancer Biol; 1990 Feb; 1(1):59-68. PubMed ID: 2133112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transactivation of adenovirus E2-early promoter by E1A and E4 6/7 in the context of viral chromosome.
    Swaminathan S; Thimmapaya B
    J Mol Biol; 1996 May; 258(5):736-46. PubMed ID: 8637006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus E4 open reading frame 4-induced dephosphorylation inhibits E1A activation of the E2 promoter and E2F-1-mediated transactivation independently of the retinoblastoma tumor suppressor protein.
    Mannervik M; Fan S; Ström AC; Helin K; Akusjärvi G
    Virology; 1999 Apr; 256(2):313-21. PubMed ID: 10191196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an ovine atadenovirus gene whose product activates the viral E2 promoter: possible involvement of E2F-1.
    Kümin D; Hofmann C; Uckert W; Both GW; Löser P
    Virology; 2004 Jan; 318(1):79-89. PubMed ID: 14972537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus type 12 early region 1A expresses a 52R protein repressing the trans-activating activity of transcription factor c-Jun/AP-1.
    Brockmann D; Feng L; Kröner G; Tries B; Esche H
    Virology; 1994 Feb; 198(2):717-23. PubMed ID: 8291251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
    Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
    Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A TATA box implicated in E1A transcriptional activation of a simple adenovirus 2 promoter.
    Wu L; Rosser DS; Schmidt MC; Berk A
    Nature; 1987 Apr 2-8; 326(6112):512-5. PubMed ID: 2951598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1A.
    Duyndam MC; van Dam H; Smits PH; Verlaan M; van der Eb AJ; Zantema A
    Oncogene; 1999 Apr; 18(14):2311-21. PubMed ID: 10327051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription activation by the adenovirus E1a protein.
    Lillie JW; Green MR
    Nature; 1989 Mar; 338(6210):39-44. PubMed ID: 2521923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of AP-1/ATF transcription factor activity by the adenovirus-E1A oncogene products.
    Hagmeyer BM; Angel P; van Dam H
    Bioessays; 1995 Jul; 17(7):621-9. PubMed ID: 7646484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
    Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of E1A under an E2F-1 promoter insulated with the myotonic dystrophy locus insulator reduces the toxicity of oncolytic adenovirus Ad-Delta24RGD.
    Majem M; Cascallo M; Bayo-Puxan N; Mesia R; Germa JR; Alemany R
    Cancer Gene Ther; 2006 Jul; 13(7):696-705. PubMed ID: 16498429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cis-acting element 7 bp upstream of the ESF-1-binding motif is involved in E1A 13S autoregulation of the adenovirus 12 TS2 promoter.
    Pützer BM; Gnauck J; Kirch HC; Brockmann D; Esche H
    J Gen Virol; 1997 Apr; 78 ( Pt 4)():879-91. PubMed ID: 9129662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus.
    Berk AJ
    Oncogene; 2005 Nov; 24(52):7673-85. PubMed ID: 16299528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rb may act as a transcriptional co-activator in undifferentiated F9 cells.
    Bocco JL; Reimund B; Chatton B; Kedinger C
    Oncogene; 1993 Nov; 8(11):2977-86. PubMed ID: 8414500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oswald F; Lovec H; Möröy T; Lipp M
    Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adenovirus E4 gene, in addition to the E1A gene, is important for trans-activation of E2 transcription and for E2F activation.
    Reichel R; Neill SD; Kovesdi I; Simon MC; Raychaudhuri P; Nevins JR
    J Virol; 1989 Sep; 63(9):3643-50. PubMed ID: 2527310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transactivation by the adenovirus E1A gene.
    Nevins JR; Raychaudhuri P; Yee AS; Rooney RJ; Kovesdi I; Reichel R
    Biochem Cell Biol; 1988 Jun; 66(6):578-83. PubMed ID: 3048331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The carboxy-terminal exon of the adenovirus E1A protein is required for E4F-dependent transcription activation.
    Bondesson M; Svensson C; Linder S; Akusjärvi G
    EMBO J; 1992 Sep; 11(9):3347-54. PubMed ID: 1387083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple regions of v-Fos protein involved in the activation of AP1-dependent transcription: is trans-activation crucial for transformation?
    Lucibello FC; Neuberg M; Jenuwein T; Müller R
    New Biol; 1991 Jul; 3(7):671-7. PubMed ID: 1751449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.